Skip to main content
Premium Trial:

Request an Annual Quote

Perlegen Wins $2.1M NIDA Grant to Study Genetics of Nicotine Addiction

NEW YORK, Nov. 17 (GenomeWeb News) - Perlegen Sciences has received a $2.1 million contract from the US National Institute on Drug Abuse to study genetic variations and candidate genes associated with nicotine addiction, the firm said today.

 

Scientists at WashingtonUniversity in St. Louis will use Perlegen technology to analyze more than 1.5 million SNPs across the genome in people highly addicted to nicotine. They will compare their findings with those conducted on people who are not addicted to nicotine.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.